NASDAQ: BMRNBiomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?
Insider buying vs selling
Have Biomarin Pharmaceutical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Henry J. Fuchs | President Worldwide RD | 2024-09-13 | 12,098 | $84.90 | $1.03MSell |
| Erin Burkhart | GVP Chief Accounting Officer | 2024-08-13 | 714 | $90.00 | $64.26kSell |
| Brian Mueller | EVP Chief Financial Officer | 2024-06-28 | 588 | $82.33 | $48.41kSell |
| Elaine J. Heron | Director | 2024-06-03 | 5,047 | $63.10 | $318.47kBuy |
| Richard A. Meier | Director | 2024-06-03 | 6,600 | $63.10 | $416.46kBuy |
| Richard A. Meier | Director | 2024-06-03 | 5,451 | $76.41 | $416.51kSell |
| Elaine J. Heron | Director | 2024-06-03 | 4,168 | $76.41 | $318.48kSell |
| Brian Mueller | EVP Chief Financial Officer | 2024-05-30 | 5,000 | $63.10 | $315.50kBuy |
| Brian Mueller | EVP Chief Financial Officer | 2024-05-30 | 5,000 | $75.19 | $375.95kSell |
| George Eric Davis | EVP Chief Legal Officer | 2024-05-28 | 38,071 | $74.46 | $2.83MSell |
BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BMRN insiders and whales buy or sell their stock.
BMRN Shareholders
What type of owners hold Biomarin Pharmaceutical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 11.94% | 22,738,349 | $1.62B | Institution |
| Vanguard Group Inc | 9.98% | 18,994,038 | $1.35B | Institution |
| Primecap Management Co | 9.87% | 18,790,085 | $1.34B | Institution |
| Dodge Cox | 7.32% | 13,930,493 | $991.02M | Institution |
| Capital Research Global Investors | 5.09% | 9,692,566 | $689.53M | Institution |
| State Street Corp | 5.06% | 9,636,020 | $685.51M | Institution |
| Viking Global Investors LP | 3.71% | 7,063,564 | $502.50M | Institution |
| Ameriprise Financial Inc | 2.47% | 4,701,326 | $334.45M | Institution |
| Avoro Capital Advisors LLC | 2.39% | 4,557,416 | $324.21M | Institution |
| Norges Bank | 1.90% | 3,619,503 | $257.49M | Institution |
BMRN vs Biotech Stocks
Biomarin Pharmaceutical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.